Sabar Karimah Es bought CAPR

April 1, 2026 · Form 4 insider transaction

Sabar Karimah Es bought 53,735 shares of Capricor Therapeutics, Inc. at $4.86 per share, a transaction worth $261.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.

Direction
Acquired (buy-side)
Shares
53,735
Price
$4.86
Total value
$261.2K
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 1, 2026
Filing dateApril 1, 2026
Shares owned after53,735
OwnershipDirect
10b5-1 planNo
AmendedNo
View the original Form 4 on SEC EDGAR